These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24926467)

  • 21. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.
    Xavier MJ; Roman SD; Aitken RJ; Nixon B
    Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.
    Malzkorn B; Wolter M; Riemenschneider MJ; Reifenberger G
    Brain Pathol; 2011 Nov; 21(6):619-32. PubMed ID: 21939466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology.
    Alelú-Paz R; Ashour N; González-Corpas A; Ropero S
    J Signal Transduct; 2012; 2012():956958. PubMed ID: 22852080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting epigenetic mechanisms of resistance to chemotherapy in gliomas.
    Skouras P; Markouli M; Papadatou I; Piperi C
    Crit Rev Oncol Hematol; 2024 Dec; 204():104532. PubMed ID: 39406277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone Modifying Enzymes and Chromatin Modifiers in Glioma Pathobiology and Therapy Responses.
    Ciechomska IA; Jayaprakash C; Maleszewska M; Kaminska B
    Adv Exp Med Biol; 2020; 1202():259-279. PubMed ID: 32034718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
    Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
    BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
    Maleszewska M; Kaminska B
    Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma.
    Huang R; Qian D; Hu M; Zhang X; Song J; Li L; Chen H; Wang B
    Oncol Lett; 2015 Nov; 10(5):2812-2820. PubMed ID: 26722247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic modulation of metabolism in glioblastoma.
    Dong Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
    Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
    Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
    Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
    Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE ANALYSIS OF LGI1 GENE EPIGENETIC ALTERATIONS BY MEANS OF POSTTRANSLATIONAL H3 HISTONE MODIFICATIONS IN MALIGNANT GLIOMAS.
    Semenova EV; Volnitsky AV; Filatov MV
    Tsitologiia; 2016; 58(5):335-9. PubMed ID: 30188624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.
    Li L; Wang Y
    J Biol Chem; 2017 Jul; 292(28):11951-11959. PubMed ID: 28546430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of DNA methylation in adult diffuse gliomas.
    Aoki K; Natsume A
    Brain Tumor Pathol; 2019 Apr; 36(2):84-91. PubMed ID: 30937703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma.
    Ohka F; Natsume A; Motomura K; Kishida Y; Kondo Y; Abe T; Nakasu Y; Namba H; Wakai K; Fukui T; Momota H; Iwami K; Kinjo S; Ito M; Fujii M; Wakabayashi T
    PLoS One; 2011; 6(8):e23332. PubMed ID: 21829728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
    Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
    BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.